U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

All Approvals and Tentative Approvals
February 1969

This report includes approvals of NDAs, BLAs, ANDAs, and approved supplements to those applications, and tentative ANDA/NDA approvals during the selected month. This report does not include BLAs/NDAs and supplements to those applications approved by CBER.

Click on the Drug Name and Application Number to see information about the drug (for example, regulatory history, labeling, reviews by FDA staff).

This report was produced on May 06, 2024.

Approval Date Drug Name Submission Active Ingredients Company Submission Classification * Submission Status
02/03/1969 QUIDE
NDA #013615		 ORIG-1 PIPERACETAZINE DOW PHARM Type 1 - New Molecular Entity Approval
02/03/1969 TALWIN 50
NDA #016732		 ORIG-1 PENTAZOCINE HYDROCHLORIDE SANOFI AVENTIS US Type 2 - New Active Ingredient Approval
02/11/1969 VIBRAMYCIN
NDA #050006		 SUPPL-13 DOXYCYCLINE PFIZER Labeling Approval
02/11/1969 VIBRAMYCIN
NDA #050006		 SUPPL-14 DOXYCYCLINE PFIZER Manufacturing (CMC) Approval
02/11/1969 ILOTYCIN
NDA #050368		 SUPPL-13 ERYTHROMYCIN DISTA Manufacturing (CMC) Approval
02/17/1969 VALISONE
NDA #016740		 ORIG-1 BETAMETHASONE VALERATE SCHERING Type 3 - New Dosage Form Approval
02/19/1969 BICILLIN L-A
NDA #050141		 SUPPL-140 PENICILLIN G BENZATHINE KING PHARMS LLC Labeling Approval
02/28/1969 LINCOCIN
NDA #050316		 SUPPL-30 LINCOMYCIN HYDROCHLORIDE PHARMACIA AND UPJOHN Manufacturing (CMC) Approval
Back to Top